AU Patent

AU2012284265B2 — Methods for the synthesis of functionalized nucleic acids

Assigned to Wave Life Sciences Pte Ltd · Expires 2017-08-17 · 9y expired

What this patent protects

Described herein are methods for the synthesis of derivatives of thiosulfonate reagents. Said reagents have utility for the synthesis of phosphorothiotriesters from H- phosphonates in a stereospecific fashion.

USPTO Abstract

Described herein are methods for the synthesis of derivatives of thiosulfonate reagents. Said reagents have utility for the synthesis of phosphorothiotriesters from H- phosphonates in a stereospecific fashion.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012284265B2
Jurisdiction
AU
Classification
—
Expires
2017-08-17
Drug substance claim
No
Drug product claim
No
Assignee
Wave Life Sciences Pte Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.